Ventral Hernias
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Antimicrobial Hernia Repair Device
Research Leaders
7 sponsors active, led by Cook Group Incorporated
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
The Effect of Laparoscopically Closing the Hernia Defect in Laparoscopic Ventral Hernia Repair on Postoperative Pain
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Antimicrobial Hernia Repair Device
Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation
Abdominal Binder to Reduce Pain and Seroma Formation
Research Network
Common Treatments
- Antimicrobial Hernia Repair Device1
- The Hernia Gap Is Sutured Intracorporally1
- Zenapro Hybrid Hernia Repair Device1
- Proceed Ventral Patch Placement1
- Eto Garments1
Active Sponsors
- Cook Group Incorporated2
- Hvidovre University Hospital2
- University Hospital, Ghent1
- Johnson & Johnson1
- University of Copenhagen1
Top Investigators
Jules Bordet Institute
Individual Purchaser
University Hospital, Ghent
University Hospital HVidovre
Related Conditions
- Incisional Hernias1
- Cytoreductive Surgery1
- Umbilical Hernias1